ArticlePloS one2026
Short-term forecasting and impact analysis of COVID-19 and the stock market in Morocco using ARIMA.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to predict the short-term trends of confirmed COVID-19 cases and the MASI stock index in Morocco using the ARIMA method. COVID-19 case data were obtained from Our World in Data, while MASI stock market data were obtained from Investing.com. The dataset covered the period from March 2, 2020 to April 28, 2022. To develop the predictive model, data from March 2, 2020 to April 28, 2022, were used for training. Data from April 22, 2022 to April 28, 2022, were used for model fitting for COVID-19 cases, and from April 25, 2022 to April 29, 2022, for the MASI index. Based on these models, we conducted short-term forecasts for April 29, 2022 to May 1, 2022, for COVID-19 cases, and May 4, 2022 to May 6, 2022, for the MASI index. The forecasting accuracy was mainly evaluated using the mean absolute percentage error (MAPE). Furthermore, we applied the Granger causality test to investigate the potential directional relationship between COVID-19 case trends and MASI index fluctuations. To the best of our knowledge, this is the first study to perform short-term forecasting of both COVID-19 cases and the MASI stock index in Morocco while also assessing their dynamic interplay, providing a novel contribution to the intersection of epidemiological and financial modeling in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.